Home
About
Overview
Sharing Data
ORCID
Help
History (18)
Re: 18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial.
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme.
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn's Disease.
Transmural Healing in Inflammatory Bowel Disease.
Emerging treatment options for extraintestinal manifestations in IBD.
See All 18 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Emerging treatment options for extraintestinal manifestations in IBD.
Emerging treatment options for extraintestinal manifestations in IBD. Gut. 2021 04; 70(4):796-802.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Biological Therapy
Humans
Inflammatory Bowel Diseases
Tumor Necrosis Factor-alpha
authors with profiles
David Rubin